NCT00589095终止不适用
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 5
- 试验地点
- 1
- 主要终点
- To detect the early "local" treatment responses from the physician recognized GBM "gross tumor volume" (GTV)
研究概览
简要总结
The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and clinical responses to radiation therapy with or without chemotherapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The presence of a primary brain tumor that cannot be completely resected that requires radiation therapy with or without chemotherapy.
排除标准
- •Patients who do not have a primary brain tumor or who are unable to tolerate the environment of the MRI scanner
结局指标
主要结局
To detect the early "local" treatment responses from the physician recognized GBM "gross tumor volume" (GTV)
时间窗: Upon completion of study
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain MetastasesBrain MetastasesGlioma of BrainMetastatic MelanomaBrain TumorNCT03698162University of Southern California15
Unknown
不适用
3T MRI to Predict TACE Response of HCCCarcinoma, HepatocellularNCT02070822National Taiwan University Hospital100
已完成
不适用
Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone TumorsBone TumorSarcomaNCT00598741Memorial Sloan Kettering Cancer Center61
已完成
不适用
Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver MetastasesColorectal Liver MetastasesNCT01255007University Health Network, Toronto50
招募中
2 期
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE TrialGlioblastoma, IDH-WildtypeNCT06319027ECOG-ACRIN Cancer Research Group100